🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

10 results for “Yung NA” Clear

  1. Fimasartan and Rosuvastatin

    Yung NA

    Essential Hypertension, Dyslipidemia

    phase 3 small molecule completed

    1 trial

  2. dabigatran

    Yung NA

    Atrial Fibrillation

    phase 3 small molecule active

    1 trial

  3. Prednisone + Jakavi(ruxolitinib)

    Yung NA

    GVHD - Graft-Versus-Host Disease

    phase 2 small molecule active

    1 trial

  4. gemcitabine

    Yung NA

    Muscle Invasive Bladder Urothelial Carcinoma

    phase 2 small molecule active

    1 trial

  5. BRI-1501

    Yung NA

    Gastric Ulcer

    phase 1 small molecule completed

    1 trial

  6. Fimasartan

    Yung NA

    Hypertension

    phase 1 small molecule completed

    1 trial

  7. Fimasartan

    Yung NA

    Essential Hypertension

    phase 1 small molecule completed

    1 trial

  8. Fimasartan/Atorvastatin Combination Tablet

    Yung NA

    Hypertension

    phase 1 small molecule completed

    1 trial

  9. Rabeprazole Sodium 10mg

    Yung NA

    Gastroesophageal Reflux Disease

    phase 1 small molecule completed

    1 trial

  10. Pregabalin

    Yung NA

    Diabetic Peripheral Neuropathy

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources